Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioma 8 Multiple Myeloma 7 Wilms Tumor 6 Sarcoma 6 Rhabdoid Tumor 6 Medulloblastoma 6 Rhabdomyosarcoma 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Neuroblastoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Histiocytosis, Langerhans-Cell 5 Hepatoblastoma 5 Ependymoma 5 Central Nervous System Neoplasms 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Osteosarcoma 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Sarcoma, Ewing 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Neoplasms 2 Neoplasm Metastasis 2

Interventions

Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 liposomal doxorubicin 1 dehydroftorafur 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 Zidovudine 1 X-Rays 1 Vincristine 1 Valganciclovir 1 Sirolimus 1 Sigmoidoscopy 1 Sentinel Lymph Node Biopsy 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Proctoscopy 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Mitozytrex 1 Mitomycin 1 Melphalan 1 Interferon-alpha 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 Filgrastim 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × HIV Infections × X-Rays × Clear all

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡